Quote:

---

So far, no BPs want to be part of the MANF story.

---

You're making an incorrect assumption here. Just because the company hasn't accepted and publicly announced a big pharma partnership doesn't mean there isn't big pharma interest in MANF.

We know from Gerald's presentations and blogs that there is significant pharma interest in LymPro. The company has elected to not accept the early partnership offers and is holding out to maximize the value of the asset, in particular waiting for the retrospective study data to be finalized. While waiting, they also acquired LPC funding of $20MM that strengthened their financial position and made it easier to reject any lowball offers already made.

So just because there hasn't been public announcement of a pharma partnership for MANF doesn't automatically translate into the statement that there is no big pharma interest.